Article thumbnail

Viable Newcastle Disease Vaccine Strains in a Pharmaceutical Dump

By Antonella Amendola, Silvia Bianchi, Marta Canuti, Alessandra Zappa, Giovanna Zanoni, Raffaella Koncan, Elisabetta Tanzi, Giuseppe Cornaglia, Alessandro Remo Zanetti and Giuseppe Tridente


To assess the viability of discarded and buried vaccine strains, we examined vaccines that had been buried for >20 years in an industrial waste dump in the city of Milan, Italy. Viability results showed potential biological risk associated with uncontrolled burial of pharmaceutical industry waste, including some live vaccines

Topics: Dispatch
Publisher: Centers for Disease Control and Prevention
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2007). Adaptation of a velogenic Newcastle disease virus to Vero cells: assessing the molecular changes before and after adaptation. Vet Res Commun.
  2. (1995). Advisory Committee on Dangerous Pathogens. Categorisation of biological agents according to hazard and categories of containment. Sudbury (UK): Health and Safety Executive Books;
  3. (2001). Detection and differentiation of Newcastle disease virus (avian paramyxovirus type 1). Avian Pathol.
  4. Effect of fusion protein cleavage site mutations on virulence of Newcastle disease virus: non-virulent cleavage site mutations revert to virulence after one passage in chicken brain.
  5. Human health implications of avian infl uenza viruses and paramyxoviruses.
  6. (2007). Newcastle disease vaccines. Biotechnol Adv. 1998;16:343–66. Address for correspondence: Antonella Amendola,
  7. (2001). Newcastle disease virus: macromolecules and opportunities. Avian Pathol.
  8. Newcastle disease.
  9. (2004). World Organization for Animal Health. Newcastle disease. In: Manual of diagnostic tests and vaccines for terrestrial animals.